Abstract :

Cystic fibrosis is a genetic disorder that primarily affects the lungs and digestive system. It is caused by mutations in the CF trans-membrane conductance regulator gene, which encodes for a protein involved in the regulation of salt and water movement across cell membranes. This mutation leads to the production of thick, sticky mucus that can clog the airways and obstruct the pancreas. Top of Form

Research efforts have significantly intensified since the identification of the CF trans-membrane conductance regulator gene, which harbors over 2000 distinct mutations. CF trans-membrane conductance regulator modulators, particularly transformative for patients with prevalent mutations like F508del, have the potential to prevent significant complications if initiated early in childhood. However, for individuals with rare CF trans-membrane conductance regulator mutations, the development of a treatment strategy remains to be established.

---

Keywords :

B. Pratiksha, C. Navyasri, Dwip Jyoti Kalita, Shahzad Alam, T. Rama Rao

---

References :

1. Tori M.Endres; What is cystic fibrosis; JAMA network; 2022(January), 327(2), 191.
2. Christine E.Bear; Purification and function of the cystic fibrosis trans-membrane conductance regulator; Acell press journal; 1992(February),68(4), 809-818.
3. Stanley F LO; Adavance in thr diagnosis and management of cystic fibrosis in the genomic era; Clinical chemistry; 2018(June), 64(6), 898-908.
4. US cystic fibrosis foundation; John’s Hopkins university hospital for sick children; Clinical and functional translation of CFTR₂; https://www.cftr.org\files\CFTR₂13 2015(August)..
5. Carroll E.cross; cystic fibrosis in adults; Clinical reviews in allergy and immunology; 2003(December),25,275-287.
6. Sahana rao; NICE guidance in diagnosis and management of cystic fibrosis; British medical journal; 2021(February), 106(1),31-34.
7. Brock DJ(1979); Methylum belli ferylguanidino benoate reaction protease and premature diagnosis of cystic fibrosis, Lancet, 1245.
8. Iwona pranke; Therapeutics in cystic fibrosis; Clinical revolution and new challenges; Med.science; 2024(March); 40,258-267.